FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Chinese Auto Sector May Not Go Back to 'Golden Era,' Nio Chief Says

By

China's automobile sector may not return to its "golden era" as domestic car sales dropped for the seventh straight month in April, Reuters reported Thursday, citing Nio's (HKG:9866, SGX:NIO) top executive.

The country is "no longer a growth market, but rather a saturated market," as automobile ownership reached 370 million vehicles, the report quoted Nio CEO William Li as saying.

Li also reportedly said the Chinese auto industry is yet to see a recovery despite continued strong export levels.

China remains the pure electric vehicle maker's primary market, the chief executive reportedly said when asked about plans to expand overseas.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Hong Kong Stocks Rebound on U.S.-Iran Truce Talks; Creality 3D Technology Jumps on Debut

Hong Kong stocks ended higher Friday as investors awaited further details on a proposed agreement to reopen the Strait of Hormuz and extend the ceasefire between the United States and Iran.The Hang Seng Index rose 0.7%, or 176.23 points, to close at 25,182.39, while the Hang Seng China Enterprises Index gained 0.7%, or 61.41 points, to finish at 8,425.82.Sources told Reuters that U.S. and Iranian negotiators reached a preliminary agreement Thursday to extend their ceasefire and ease restrictions on shipping through the Strait of Hormuz.The proposal has yet to receive approval from U.S. President Donald Trump, while Iranian state media said a final agreement has not been reached.The plan would extend the truce by 60 days and allow commercial traffic to resume through the strategic waterway as both sides continue negotiations, Reuters said, citing four sources familiar with the matter.In corporate news, Shenzhen Creality 3D Technology (HKG:3388) made its Hong Kong debut, closing over 21% higher at HK$22.80, compared with the offer price of HK$18.80.Innovent Biologics (HKG:1801) advanced 11% after securing an oncology licensing deal with New York-based pharmaceutical giant Pfizer that could potentially be worth up to $10.5 billion.

$^HSI$HKG:1801$HKG:3388
Asia

Shanghai Hollywave Electronic System Appoints CFO

Shanghai Hollywave Electronic System (SHA:688682) appointed audit manager Su Tingting as chief financial officer.Su succeeds Zhang Xu, who resigned due to personal reasons, according to a Friday filing with the Shanghai bourse.Shares of the technology and industrial software provider closed 12% lower Friday.

$SHA:688682
Asia

Sandoz Seeks EU Anti-Dumping Duties Against Chinese Antibiotic Active Ingredients

Swiss generic drug manufacturer Sandoz filed an anti-dumping complaint against Chinese imports of amoxicillin before the European Commission, it said in a Thursday news release.The drugmaker said Chinese imports engaged in clear market-manipulating behavior through sustained below-cost pricing of state-subsidized penicillin active pharmaceutical ingredients, it said.With up to 90% of antibiotic APIs primarily made in China, Europe faces a "crucial strategic vulnerability" detrimental to public health, Sandoz CEO Richard Saynor said.

$^SSEC$^SZSE